tiprankstipranks
Trending News
More News >
Hoth Therapeutics (HOTH)
:HOTH
US Market

Hoth Therapeutics (HOTH) Income Statement

Compare
483 Followers

Hoth Therapeutics Income Statement

Last quarter (Q3 2025), Hoth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Hoth Therapeutics's net income was $-4.11M. See Hoth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -66.83K$ 0.00$ 0.00
Operating Expenses
$ 8.22M$ 7.69M$ 11.07M$ 14.10M$ 7.30M
Depreciation and Amortization
$ 8.22M$ 7.69M$ 11.07M$ 0.00$ 1.04K
EBITDA
$ 27.13K$ -153.15K$ 0.00$ -14.10M$ -7.30M
Operating Income
$ -8.22M$ -7.69M$ -11.07M$ -14.10M$ -7.30M
Other Income/Expenses
$ 27.13K$ -153.15K$ -306.40K$ -212.26K$ 104.16K
Pretax Income
$ -8.19M$ -7.85M$ -11.37M$ -14.31M$ -7.20M
Net Income
$ -8.19M$ -7.85M$ -11.68M$ -14.31M$ -7.20M
Per Share Metrics
Basic EPS
$ -1.28$ -2.30$ -9.75$ -16.03$ -14.56
Diluted EPS
$ -1.28$ -2.30$ -9.75$ -16.03$ -14.56
Weighted Average Shares Outstanding
6.38M 3.41M 1.20M 893.20K 494.51K
Weighted Average Shares Outstanding (Diluted)
6.38M 3.41M 1.20M 893.20K 494.51K
Currency in USD

Hoth Therapeutics Earnings and Revenue History